Journal of The Japanese Stomatological Society
Online ISSN : 2185-0461
Print ISSN : 0029-0297
ISSN-L : 0029-0297
Volume 52, Issue 3
Displaying 1-4 of 4 articles from this issue
  • Kiyohide ISHIHATA
    2003 Volume 52 Issue 3 Pages 109-123
    Published: May 10, 2003
    Released on J-STAGE: January 31, 2011
    JOURNAL FREE ACCESS
    This study assessed procedures for analyzing facial morphology and defined criteria for diagnosing facial asymmetry.
    The facial morphology of 10 female patients diag nosedas having facial asymmetry and treated by mandibular osteotomy was measured by a non-contact three-dimensional measuring apparatus preoperatively and again 3 months postoperatively.
    As a control group, three-dimensional data on the facial morphology of 20 normal females recorded by the same instrument were also analyzed.
    The results were as follows:
    1. The standard values of X-, Y- and Z-coordinates of 98 facial measurement points were defined by computing the data of normal subjects. It was con firmedthat the area and degree of asymmetry of a patient's face could be assessed based on standard values.
    2. It was shown that the virtual facial midline calculated for the patient's face was useful for assess ingand demonstrating the lateral deviation of the facial midline.
    3. It was confirmed by three-dimensional analysis of the 98 measurement points that facial measure mentpoints lower than alare deviated significantly and tended to protrude in comparison with those of normal subjects or those on the opposite side.
    4. Following mandibular osteotomy, facial asym metryimproved but slight asymmetry remained.
    5. It was proven that the analysis method and standard values confirmed in this study were useful in the treatment and diagnosis of patients with facial asymmetry.
    Download PDF (3411K)
  • Hiroshi IWAKI, Teruo AMAGASA, Shouji ENOMOTO, Kiyoshi HARADA, Ken-ichi ...
    2003 Volume 52 Issue 3 Pages 124-133
    Published: May 10, 2003
    Released on J-STAGE: January 31, 2011
    JOURNAL FREE ACCESS
    The efficacy and safety of autologous blood trans fusionwith the support of r Hu EPO in 47 patients with oral malignant tumors were evaluated by a multicenter study.
    The patients consisted of 30 men and 17 women.The age of the patients ranged from 41 to 81 (aver age: 60.7±9.7 years old).
    The most frequent site of the lesions was tongue, followed by lower jaw, upper jaw, and floor of the mouth. Ninety-four percent of the lesions were squamous cell carcinoma and 66% were classified into Stage III or Stage IV.
    Twelve patients received surgery alone and 35 patients received radiation therapy and/or chemother apybefore surgery.
    A blood volume of 800 ml or 1, 200 ml was success fullycollected within three weeks with the support of r Hu EPO treatment in 45 (96%) out of 47 patients.
    Allogenous blood transfusion was avoided in 33 (72%) out of 46 patients who underwent autologous blood donation prior to operation. Hemoglobin levels of the patients significantly decreased by blood donation but this did not affect the patients' conditionsfor surgery.
    As a result, efficacy scores based on the increase of hemoglobin levels prior to operation were “excellent or effective” in 24 (51%) out of 47 patients. No adverse event was observed during the study period.
    From the above findings, epoetin alfa treatment for autologous blood donation in patients with oral malignant tumors was considered effective and safe.
    Download PDF (1035K)
  • Atsushi OGAWA, Yoshiyasu FUKUTA, Shotaro SEKI, Toshihiro OHTA, Yuichir ...
    2003 Volume 52 Issue 3 Pages 134-138
    Published: May 10, 2003
    Released on J-STAGE: January 31, 2011
    JOURNAL FREE ACCESS
    Local recurrence after curative therapy is an importantfactor influencing the prognosis of oral carcinoma patients. We have evaluated the time to recurrence and treatment results in local recurrence. This study included 36 patients with local recurrence among 280 patients who underwent curative treatment for primary oral carcinomas between 1975 and 2000.
    Intervals between the end of initial treatment and recurrence ranged from 2 to 51 months, with a mean of 12.1 months. The mean interval was 22.6 months in patients surviving after local recurrence and was 6.1 months in patients who died. Twenty-three patientswith local recurrence were considered potentially curable by retreatment, 13 patients being treated only for palliation. Curative treatments consist of surgery alone in 4 patients, and surgery following chemotherapy in 3 patients, and surgery following chemotherapy and radiotherapy in 16 patients. The cause-specific 5-year cumulative survival rate after local recurrence was 58.2% in curative cases and 23.1% in palliative cases.
    Download PDF (677K)
  • Kazutada USAMI, Yasushi HAYASHI, Hirotomo HATTORI, Yukio SUMI, Iwai TO ...
    2003 Volume 52 Issue 3 Pages 139-142
    Published: May 10, 2003
    Released on J-STAGE: January 31, 2011
    JOURNAL FREE ACCESS
    Local injection of OK-432 is a conservative therapy for cystic lesions. One mechanism of this therapy is thought to be tissue adhesion due to inflammatory response after injection.
    Recently, this therapy has been the first choice for cystic lymphangioma.
    We report the case of a hen-egg-sized plunging ranula treated successfully with OK-432 local injection.
    The patient was a 13-year-old girl. Swelling appearedin the left submandibular region starting in April 1999.
    The lesion was punctured under local anesthesia and about 25 ml of viscid internal fluid was aspirated with a syringe. Then 10ml of OK-432 solution (0.1 KE/ml) was injected into the cyst.
    Five months later, the swelling had disappeared almost completely. No evidence of recurrence was observed during follow-up and no abnormalities were seen in the flow of saliva.
    Download PDF (1076K)
feedback
Top